272 related articles for article (PubMed ID: 31880318)
21. TOX expression decreases with progression of colorectal cancers and is associated with CD4 T-cell density and Fusobacterium nucleatum infection.
Chen T; Li Q; Zhang X; Long R; Wu Y; Wu J; Fu X
Hum Pathol; 2018 Sep; 79():93-101. PubMed ID: 29792893
[TBL] [Abstract][Full Text] [Related]
22.
Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM
Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840
[TBL] [Abstract][Full Text] [Related]
23. Comparative Analysis of Colon Cancer-Derived Fusobacterium nucleatum Subspecies: Inflammation and Colon Tumorigenesis in Murine Models.
Queen J; Domingue JC; White JR; Stevens C; Udayasuryan B; Nguyen TTD; Wu S; Ding H; Fan H; McMann M; Corona A; Larman TC; Verbridge SS; Housseau F; Slade DJ; Drewes JL; Sears CL
mBio; 2021 Feb; 13(1):e0299121. PubMed ID: 35130731
[TBL] [Abstract][Full Text] [Related]
24. The Amount of Bifidobacterium Genus in Colorectal Carcinoma Tissue in Relation to Tumor Characteristics and Clinical Outcome.
Kosumi K; Hamada T; Koh H; Borowsky J; Bullman S; Twombly TS; Nevo D; Masugi Y; Liu L; da Silva A; Chen Y; Du C; Gu M; Li C; Li W; Liu H; Shi Y; Mima K; Song M; Nosho K; Nowak JA; Nishihara R; Baba H; Zhang X; Wu K; Wang M; Huttenhower C; Garrett WS; Meyerson ML; Lennerz JK; Giannakis M; Chan AT; Meyerhardt JA; Fuchs CS; Ogino S
Am J Pathol; 2018 Dec; 188(12):2839-2852. PubMed ID: 30243655
[TBL] [Abstract][Full Text] [Related]
25. Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum.
Brennan CA; Nakatsu G; Gallini Comeau CA; Drew DA; Glickman JN; Schoen RE; Chan AT; Garrett WS
mBio; 2021 Apr; 12(2):. PubMed ID: 33824205
[TBL] [Abstract][Full Text] [Related]
26. Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum.
Yamauchi M; Morikawa T; Kuchiba A; Imamura Y; Qian ZR; Nishihara R; Liao X; Waldron L; Hoshida Y; Huttenhower C; Chan AT; Giovannucci E; Fuchs C; Ogino S
Gut; 2012 Jun; 61(6):847-54. PubMed ID: 22427238
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumour.
Hamada T; Liu L; Nowak JA; Mima K; Cao Y; Ng K; Twombly TS; Song M; Jung S; Dou R; Masugi Y; Kosumi K; Shi Y; da Silva A; Gu M; Li W; Keum N; Wu K; Nosho K; Inamura K; Meyerhardt JA; Nevo D; Wang M; Giannakis M; Chan AT; Giovannucci EL; Fuchs CS; Nishihara R; Zhang X; Ogino S
Eur J Cancer; 2018 Nov; 103():98-107. PubMed ID: 30219720
[TBL] [Abstract][Full Text] [Related]
28. Fusobacterium nucleatum Load Correlates with KRAS Mutation and Sessile Serrated Pathogenesis in Colorectal Adenocarcinoma.
Takeda K; Koi M; Okita Y; Sajibu S; Keku TO; Carethers JM
Cancer Res Commun; 2023 Sep; 3(9):1940-1951. PubMed ID: 37772997
[TBL] [Abstract][Full Text] [Related]
29. Relationship between Fusobacterium nucleatum and antitumor immunity in colorectal cancer liver metastasis.
Sakamoto Y; Mima K; Ishimoto T; Ogata Y; Imai K; Miyamoto Y; Akiyama T; Daitoku N; Hiyoshi Y; Iwatsuki M; Baba Y; Iwagami S; Yamashita YI; Yoshida N; Komohara Y; Ogino S; Baba H
Cancer Sci; 2021 Nov; 112(11):4470-4477. PubMed ID: 34464993
[TBL] [Abstract][Full Text] [Related]
30. Intratumoral Fusobacterium nucleatum abundance correlates with macrophage infiltration and CDKN2A methylation in microsatellite-unstable colorectal carcinoma.
Park HE; Kim JH; Cho NY; Lee HS; Kang GH
Virchows Arch; 2017 Sep; 471(3):329-336. PubMed ID: 28597080
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic accuracy of Fusobacterium nucleatum IgA and IgG ELISA test in colorectal cancer.
Kurt M; Yumuk Z
Sci Rep; 2021 Jan; 11(1):1608. PubMed ID: 33452405
[TBL] [Abstract][Full Text] [Related]
32. Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population.
Yamaoka Y; Suehiro Y; Hashimoto S; Hoshida T; Fujimoto M; Watanabe M; Imanaga D; Sakai K; Matsumoto T; Nishioka M; Takami T; Suzuki N; Hazama S; Nagano H; Sakaida I; Yamasaki T
J Gastroenterol; 2018 Apr; 53(4):517-524. PubMed ID: 28823057
[TBL] [Abstract][Full Text] [Related]
33. Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location.
Mima K; Cao Y; Chan AT; Qian ZR; Nowak JA; Masugi Y; Shi Y; Song M; da Silva A; Gu M; Li W; Hamada T; Kosumi K; Hanyuda A; Liu L; Kostic AD; Giannakis M; Bullman S; Brennan CA; Milner DA; Baba H; Garraway LA; Meyerhardt JA; Garrett WS; Huttenhower C; Meyerson M; Giovannucci EL; Fuchs CS; Nishihara R; Ogino S
Clin Transl Gastroenterol; 2016 Nov; 7(11):e200. PubMed ID: 27811909
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA MIR21 (miR-21) and PTGS2 Expression in Colorectal Cancer and Patient Survival.
Mima K; Nishihara R; Yang J; Dou R; Masugi Y; Shi Y; da Silva A; Cao Y; Song M; Nowak J; Gu M; Li W; Morikawa T; Zhang X; Wu K; Baba H; Giovannucci EL; Meyerhardt JA; Chan AT; Fuchs CS; Qian ZR; Ogino S
Clin Cancer Res; 2016 Aug; 22(15):3841-8. PubMed ID: 26957558
[TBL] [Abstract][Full Text] [Related]
35. Fusobacterium nucleatum and colorectal cancer: A mechanistic overview.
Hashemi Goradel N; Heidarzadeh S; Jahangiri S; Farhood B; Mortezaee K; Khanlarkhani N; Negahdari B
J Cell Physiol; 2019 Mar; 234(3):2337-2344. PubMed ID: 30191984
[TBL] [Abstract][Full Text] [Related]
36. TGFBR2 and BAX mononucleotide tract mutations, microsatellite instability, and prognosis in 1072 colorectal cancers.
Shima K; Morikawa T; Yamauchi M; Kuchiba A; Imamura Y; Liao X; Meyerhardt JA; Fuchs CS; Ogino S
PLoS One; 2011; 6(9):e25062. PubMed ID: 21949851
[TBL] [Abstract][Full Text] [Related]
37. Loss of CDH1 (E-cadherin) expression is associated with infiltrative tumour growth and lymph node metastasis.
Kim SA; Inamura K; Yamauchi M; Nishihara R; Mima K; Sukawa Y; Li T; Yasunari M; Morikawa T; Fitzgerald KC; Fuchs CS; Wu K; Chan AT; Zhang X; Ogino S; Qian ZR
Br J Cancer; 2016 Jan; 114(2):199-206. PubMed ID: 26742007
[TBL] [Abstract][Full Text] [Related]
38. Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy.
Yu T; Guo F; Yu Y; Sun T; Ma D; Han J; Qian Y; Kryczek I; Sun D; Nagarsheth N; Chen Y; Chen H; Hong J; Zou W; Fang JY
Cell; 2017 Jul; 170(3):548-563.e16. PubMed ID: 28753429
[TBL] [Abstract][Full Text] [Related]
39. Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: Results from two prospective cohorts and CALGB 89803 (Alliance) trial.
Kosumi K; Hamada T; Zhang S; Liu L; da Silva A; Koh H; Twombly TS; Mima K; Morikawa T; Song M; Nowak JA; Nishihara R; Saltz LB; Niedzwiecki D; Ou FS; Zemla T; Mayer RJ; Baba H; Ng K; Giannakis M; Zhang X; Wu K; Giovannucci EL; Chan AT; Fuchs CS; Meyerhardt JA; Ogino S
Eur J Cancer; 2019 Apr; 111():82-93. PubMed ID: 30826660
[TBL] [Abstract][Full Text] [Related]
40. Intratumour Fusobacterium nucleatum and immune response to oesophageal cancer.
Kosumi K; Baba Y; Yamamura K; Nomoto D; Okadome K; Yagi T; Toihata T; Kiyozumi Y; Harada K; Eto K; Sawayama H; Ishimoto T; Iwatsuki M; Iwagami S; Miyamoto Y; Yoshida N; Watanabe M; Baba H
Br J Cancer; 2023 Apr; 128(6):1155-1165. PubMed ID: 36599917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
